Best of Oncology™ 2026, Albuquerque conference hero image

Best of Oncology™ 2026, Albuquerque

Venue: Sheraton Albuquerque Airport Hotel, 2910 Yale Boulevard Southeast, Albuquerque, NM, United States

Start Date: End Date:
Register for Conference

Official conference page for Best of Oncology™ 2026, Albuquerque.

Faculty disclosures

Identification and mitigation of potential conflicts of interest

All conflict of interest has been identified and mitigated for individuals in control of contents.

Planning committee disclosure statement

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

Conference Director

Awaiting faculty disclosure.

Conference Co-Chair

Awaiting faculty disclosure.

Planning Committee

Awaiting faculty disclosure.

Session Chairs

has a financial relationship (Other) with Astra Zeneca.

has a financial relationship (Advisor) with Curio Science; financial relationship (Advisor) with Bristol Myers Squib; financial relationship (Advisor) with Johnson and Johnson.

No, I have not had a financial relationship with an ineligible company within the past 24 months.

Awaiting faculty disclosure.

Topic Presenters

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

No, I have not had a financial relationship with an ineligible company within the past 24 months.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

has a financial relationship (Researcher) with Arcus Biosciences; financial relationship (Advisor) with Astellas; financial relationship (Researcher) with BMS; financial relationship (Advisor) with Corcept Therapeutics; financial relationship (Researcher) with Crystal Genomics; financial relationship (Speaker) with Fibrogen (in-house company lecture); financial relationship (Advisor) with Gilead; financial relationship (Consultant) with Grail; financial relationship (Advisor) with Jazz Pharmaceuticals; financial relationship (Advisor) with Legend Biotech; financial relationship (Advisor) with Merus; financial relationship (Researcher) with Novartis; financial relationship (Speaker) with Pfizer (in-house company lecture); financial relationship (Speaker) with Renovo (in-house compnay lecture); financial relationship (Researcher) with Revolution Medicines; financial relationship (Advisor) with Revolution Medicines; financial relationship (Speaker) with Revolution Medicines (in-house company speaker); financial relationship (Researcher) with Roche/Genentech; financial relationship (Advisor) with Tango Therapeutics; financial relationship (Researcher) with Verastem.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Case Presenters

Awaiting faculty disclosure.

has a financial relationship (Speaker) with bristol myers squibb.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Panelists

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Awaiting faculty disclosure.

Awaiting faculty disclosure.